{"id":32632,"date":"2025-07-14T14:25:52","date_gmt":"2025-07-14T18:25:52","guid":{"rendered":"https:\/\/cdtrp.ca\/?p=32632"},"modified":"2025-07-14T14:28:19","modified_gmt":"2025-07-14T18:28:19","slug":"july-29-cdtrp-clinical-trials-group-cdtrp-ctg-meeting-dr-ruth-sapir-picchadze","status":"publish","type":"post","link":"https:\/\/cdtrp.ca\/en\/july-29-cdtrp-clinical-trials-group-cdtrp-ctg-meeting-dr-ruth-sapir-picchadze\/","title":{"rendered":"July 29 CDTRP Clinical Trials Group (CDTRP-CTG) meeting: Dr. Ruth Sapir-Picchadze"},"content":{"rendered":"
<\/a><\/span><\/div>
<\/div>

The CDTRP Clinical Trials Group (CDTRP-CTG) invites you to join our upcoming virtual clinical trials meeting on July 29th at 3 pm ET, which will discuss clinical trials, COVID-19, and vaccination.<\/p>\n

Dr. Ruth Sapir-Pichhadze will share insights from the CO2I2 Trial<\/strong> in a talk entitled:<\/p>\n

“Patient, Family, and Donor Voices Matter: Lessons Learned from the CO2I2 Trial on Maintaining Engagement and Adherence to the COVID-19 Vaccine Schedule.<\/strong>”<\/p>\n

Dr. Sapir-Pichhadze will share key insights into strategies for improving vaccine engagement and adherence among transplant populations.<\/p>\n

We encourage you to attend and take part in the open discussion<\/strong> that will occur after the presentation. We will discuss broader issues regarding clinical trials and vaccination.<\/p>\n

Register now!<\/p>\n<\/div>

<\/div>
CDTRP-CTG\u00a0expectations for meeting participation:<\/strong><\/h6>\n
    \n
  1. We expect that all attendees (members and visitors) respect the confidential information presented at\u00a0the CDTRP-CTG meetings or in subsequent correspondence by not sharing it with non-CDTRP-CTG members unless\u00a0by explicit agreement with the principal investigator.<\/li>\n
  2. We expect attendees to engage in a collegial and respectful fashion in the meeting sessions.<\/li>\n
  3. Confidential information\u00a0means all data, information, activities, ideas, study names\/acronyms and concepts relating to critical care research that are proprietary to the CTG member or her\/his collaborators, in any format and however disclosed.<\/li>\n<\/ol>\n<\/div>
    <\/div>
    REGISTRATION<\/span><\/a><\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":8,"featured_media":32635,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,75],"tags":[],"class_list":["post-32632","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","category-featured"],"_links":{"self":[{"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/posts\/32632"}],"collection":[{"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/comments?post=32632"}],"version-history":[{"count":4,"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/posts\/32632\/revisions"}],"predecessor-version":[{"id":32640,"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/posts\/32632\/revisions\/32640"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/media\/32635"}],"wp:attachment":[{"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/media?parent=32632"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/categories?post=32632"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/tags?post=32632"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}